Characterization and Immunotherapeutic Implications for a Novel Antibody Targeting Interleukin (IL)-13 Receptor α2

IL-13 regulates cancer invasion and metastasis through IL-13Rα2 via ERK/AP-1 pathway in mouse model of human ovarian cancer

(2011) Toshio Fujisawa et al.   INTERNATIONAL JOURNAL OF CANCER

In vivo Cytotoxicity of Type I CD20 Antibodies Critically Depends on Fc Receptor ITAM Signaling

(2010) S. de Haij et al.   CANCER RESEARCH

Interleukin 13 Mediates Signal Transduction through Interleukin 13 Receptor  2 in Pancreatic Ductal Adenocarcinoma: Role of IL-13 Pseudomonas Exotoxin in Pancreatic Cancer Therapy

(2010) T. Shimamura et al.   CLINICAL CANCER RESEARCH

Complement activation mediates cetuximab inhibition of non-small cell lung cancer tumor growth in vivo

(2010) Yi-Fan Hsu et al.   Molecular Cancer

A Novel Role of Interleukin-13 Receptor  2 in Pancreatic Cancer Invasion and Metastasis

(2009) T. Fujisawa et al.   CANCER RESEARCH

Interleukin-13 Receptor  2, EphA2, and Fos-Related Antigen 1 as Molecular Denominators of High-Grade Astrocytomas and Specific Targets for Combinatorial Therapy

(2008) J. Wykosky et al.   CLINICAL CANCER RESEARCH

Targeting IL-13Rα2-positive cancer with a novel recombinant immunotoxin composed of a single-chain antibody and mutated Pseudomonas exotoxin

(2008) Mitomu Kioi et al.   MOLECULAR CANCER THERAPEUTICS